FindTrial
Sign In

A randomized controlled trial for comparison of clinical efficacy between acupuncture of Yuji(LU10) acupoint and Taichong(LR3) acupoint in the treatment of primary hypertension

Comparison of clinical efficacy between acupuncture of Yuji(LU10) acupoint and Taichong(LR3) acupoint in the treatment of primary hypertension

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018758
Enrollment
Unknown
Registered
2018-09-18
Start date
2018-09-20
Completion date
Unknown
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

essential hypertension

Interventions

experimental group:acupuncture LU10
control group:acupuncture LR3

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Belonging to grade 1 and grade 2 of essential hypertension meet the diagnostic criteria; 2. Patients with a course of 1 year or more; 3. Those aged between 45 and 65 years; 4. Voluntary participation and compliance; 5. Taking medication with blood pressure still out of normal range and stable.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, liver and kidney dysfunction and moderate to severe diabetes; 2. Patients who cannot tolerate acupuncture treatment; 3. Planned pregnancy, pregnancy and lactation; 4. Participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Blood pressure;—

Countries

China

Contacts

Public ContactMeichen Gai

Beijing University of Chinese Medicine

1025989940@qq.com+86 18810830969

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026